Zhang Xiaoyan Michelle 4
4 · Ikena Oncology, Inc. · Filed Nov 23, 2021
Insider Transaction Report
Form 4
Zhang Xiaoyan Michelle
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2021-11-22+176,699→ 176,699 totalExercise: $13.75Exp: 2031-11-21→ Common Stock (176,699 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on November 22, 2022, with the remainder vesting in 36 equal monthly installments thereafter.
Signature
/s/ Douglas R. Carlson, as Attorney-in-Fact for Xiaoyan Michelle Zhang|2021-11-23